Zealand Pharma A/S (ZLDPY)

Zealand Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,960	7,017	3,231	1,489	959	1,441
Market Cap Growth	-56.24%	117.21%	116.91%	55.28%	-33.42%	13.22%
Enterprise Value	2,423	5,793	3,013	1,511	820	1,211
PE Ratio	4.72	-	-	-	-	-
PS Ratio	3.46	806.30	63.55	99.69	57.77	45.65
PB Ratio	2.02	5.87	13.68	12.71	6.76	7.13
P/TBV Ratio	2.02	5.88	13.78	12.71	7.17	7.48
P/FCF Ratio	4.19	-	-	-	-	-
P/OCF Ratio	4.18	-	-	-	-	-
EV/Sales Ratio	1.70	665.70	59.28	101.16	49.41	38.39
EV/FCF Ratio	2.04	-	-	-	-	-
Debt / Equity Ratio	0.03	0.05	0.08	0.64	0.85	0.11
Debt / FCF Ratio	0.05	-	-	-	-	-
Asset Turnover	0.67	0.01	0.20	0.06	0.06	0.11
Inventory Turnover	-	0.85	0.69	-	0.12	-
Quick Ratio	15.08	21.11	6.23	6.73	4.80	3.71
Current Ratio	15.09	21.14	6.25	6.73	5.15	4.00
Return on Equity (ROE)	53.44%	-21.13%	-58.43%	-110.75%	-69.99%	-54.10%
Return on Assets (ROA)	32.86%	-13.81%	-19.93%	-28.30%	-25.53%	-23.29%
Return on Capital (ROIC)	34.83%	-14.80%	-22.99%	-33.41%	-31.80%	-29.12%
Earnings Yield	21.20%	-2.13%	-3.23%	-11.60%	-16.24%	-9.66%
FCF Yield	23.89%	-1.86%	-2.01%	-9.20%	-19.68%	-8.14%
Buyback Yield / Dilution	-18.37%	-17.40%	-22.49%	-7.77%	-11.73%	-13.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.